GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » McKesson Europe AG (HAM:CLS1) » Definitions » Capex-to-Operating-Income

McKesson Europe AG (HAM:CLS1) Capex-to-Operating-Income : 0.00 (As of Mar. 2022)


View and export this data going back to 2006. Start your Free Trial

What is McKesson Europe AG Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

McKesson Europe AG's Capital Expenditure for the six months ended in Mar. 2022 was €0.00 Mil. Its Operating Income for the six months ended in Mar. 2022 was €30.70 Mil.

Hence, McKesson Europe AG's Capex-to-Operating-Income for the six months ended in Mar. 2022 was 0.00.


McKesson Europe AG Capex-to-Operating-Income Historical Data

The historical data trend for McKesson Europe AG's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

McKesson Europe AG Capex-to-Operating-Income Chart

McKesson Europe AG Annual Data
Trend Dec12 Dec13 Dec14 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
Capex-to-Operating-Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.98 2.33 1.68 2.70 -

McKesson Europe AG Semi-Annual Data
Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.98 2.33 1.68 2.70 -

Competitive Comparison of McKesson Europe AG's Capex-to-Operating-Income

For the Medical Distribution subindustry, McKesson Europe AG's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


McKesson Europe AG's Capex-to-Operating-Income Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, McKesson Europe AG's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where McKesson Europe AG's Capex-to-Operating-Income falls into.



McKesson Europe AG Capex-to-Operating-Income Calculation

McKesson Europe AG's Capex-to-Operating-Income for the fiscal year that ended in Mar. 2022 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (0) / 30.7
=0.00

McKesson Europe AG's Capex-to-Operating-Income for the quarter that ended in Mar. 2022 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (0) / 30.7
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


McKesson Europe AG  (HAM:CLS1) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


McKesson Europe AG Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of McKesson Europe AG's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


McKesson Europe AG (HAM:CLS1) Business Description

Traded in Other Exchanges
N/A
Address
Stockholmer Platz 1, Stuttgart, BW, DEU, 70137
McKesson Europe AG is a medical care company that provides logistics and services to the pharmaceutical and healthcare sectors. The company operates two distinct segments: Pharmaceutical Distribution and Retail Pharmacy. The Pharmaceutical Distribution business sells wholesale pharmaceutical products and generates the majority of the company's revenue. The Retail Pharmacy segment operates its own pharmacies in addition to franchise pharmacies that provide prescriptions and over-the-counter pharmaceutical products. Geographically, the company's revenue derives predominantly from the United Kingdom, France, Germany, and other countries.

McKesson Europe AG (HAM:CLS1) Headlines

No Headlines